BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32064600)

  • 1. ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer.
    Liu ZH; Chen ML; Zhang Q; Zhang Y; An X; Luo YL; Liu XM; Liu SX; Liu Q; Yang T; Liu YM; Liu BL; Zhou AJ; Li MZ; Liu YJ; Liu ZX; Zhong Q
    Int J Cancer; 2020 Jul; 147(2):505-518. PubMed ID: 32064600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma.
    Lu SX; Zhang CZ; Luo RZ; Wang CH; Liu LL; Fu J; Zhang L; Wang H; Xie D; Yun JP
    Cancer Lett; 2017 Aug; 402():71-80. PubMed ID: 28577975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZIC2 upregulates lncRNA SNHG12 expression to promote endometrial cancer cell proliferation and migration by activating the Notch signaling pathway.
    Cai P; Li G; Wu M; Zhang B; Bai H
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.
    Deng X; Zhao Y; Wang B
    Oncol Rep; 2015 Oct; 34(4):2188-94. PubMed ID: 26238950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-1284 Inhibits the Growth and Invasion of Breast Cancer Cells by Targeting ZIC2.
    Zhang P; Yang F; Luo Q; Yan D; Sun S
    Oncol Res; 2019 Feb; 27(2):253-260. PubMed ID: 30075825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
    Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
    Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.
    Cascio S; D'Andrea A; Ferla R; Surmacz E; Gulotta E; Amodeo V; Bazan V; Gebbia N; Russo A
    J Cell Physiol; 2010 Jul; 224(1):242-9. PubMed ID: 20232316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serine/Threonine Kinase 35, a Target Gene of STAT3, Regulates the Proliferation and Apoptosis of Osteosarcoma Cells.
    Wu Z; Liu J; Hu S; Zhu Y; Li S
    Cell Physiol Biochem; 2018; 45(2):808-818. PubMed ID: 29414823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
    Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
    J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
    Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2.
    Inaguma S; Ito H; Riku M; Ikeda H; Kasai K
    Oncotarget; 2015 Sep; 6(29):28257-68. PubMed ID: 26318045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling.
    Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z
    Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
    Sirkisoon SR; Carpenter RL; Rimkus T; Anderson A; Harrison A; Lange AM; Jin G; Watabe K; Lo HW
    Oncogene; 2018 May; 37(19):2502-2514. PubMed ID: 29449694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.
    Linher-Melville K; Haftchenary S; Gunning P; Singh G
    Mol Cell Biochem; 2015 Jul; 405(1-2):205-21. PubMed ID: 25896132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR‑1271‑5p inhibits cell proliferation and induces apoptosis in acute myeloid leukemia by targeting ZIC2.
    Chen X; Yang S; Zeng J; Chen M
    Mol Med Rep; 2019 Jan; 19(1):508-514. PubMed ID: 30483794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer.
    Su F; Ren F; Rong Y; Wang Y; Geng Y; Wang Y; Feng M; Ju Y; Li Y; Zhao ZJ; Meng K; Chang Z
    Breast Cancer Res; 2012 Mar; 14(2):R38. PubMed ID: 22394684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-21: A gene of dual regulation in breast cancer.
    Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
    Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZIC2 promotes colorectal cancer growth and metastasis through the TGF-β signaling pathway.
    Liu F; Shi Z; Bao W; Zheng J; Chen K; Lin Z; Song HN; Luo X; Dong Q; Jiang L; Wang Y; Chen G; Chen X
    Exp Cell Res; 2022 Jun; 415(2):113118. PubMed ID: 35390314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
    Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
    Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.
    Aleskandarany MA; Agarwal D; Negm OH; Ball G; Elmouna A; Ashankyty I; Nuglozeh E; Fazaludeen MF; Diez-Rodriguez M; Nolan CC; Tighe PJ; Green AR; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2016 Feb; 156(1):9-20. PubMed ID: 26907764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.